The use of rituximab in idiopathic inflammatory myopathies: description of a monocentric cohort and review of the literature

Rituximab (RTX), a chimeric monoclonal antibody targeted against CD20, has been used to treat refractory inflammatory myopathies (IIM). The primary objective of this study was to retrospectively assess the efficacy of RTX in reducing disease activity in patients with IIM refractory to conventional t...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: S. Barsotti, E. Cioffi, A. Tripoli, A. Tavoni, A. d’Ascanio, M. Mosca, R. Neri
Format: Artigo
Sprog:Inglês
Udgivet: PAGEPress Publications 2018-07-01
Serier:Reumatismo
Fag:
Myositis
Refractory
Rituximab
Polymyositis
Dermatomyositis.
Online adgang:https://www.reumatismo.org/index.php/reuma/article/view/1011
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker